↓ Skip to main content

Response to combined ipilimumab and nivolumab after development of a nephrotic syndrome related to PD-1 monotherapy

Overview of attention for article published in Journal for Immunotherapy of Cancer, July 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
2 X users

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
30 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Response to combined ipilimumab and nivolumab after development of a nephrotic syndrome related to PD-1 monotherapy
Published in
Journal for Immunotherapy of Cancer, July 2019
DOI 10.1186/s40425-019-0655-4
Pubmed ID
Authors

Valerie Glutsch, Franziska Grän, Judith Weber, Anja Gesierich, Matthias Goebeler, Bastian Schilling

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 30 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 5 17%
Student > Master 4 13%
Other 3 10%
Researcher 3 10%
Professor 2 7%
Other 6 20%
Unknown 7 23%
Readers by discipline Count As %
Medicine and Dentistry 13 43%
Biochemistry, Genetics and Molecular Biology 3 10%
Psychology 2 7%
Unspecified 1 3%
Business, Management and Accounting 1 3%
Other 0 0%
Unknown 10 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 August 2019.
All research outputs
#16,053,755
of 25,385,509 outputs
Outputs from Journal for Immunotherapy of Cancer
#2,684
of 3,424 outputs
Outputs of similar age
#205,300
of 360,413 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#81
of 87 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,424 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.4. This one is in the 19th percentile – i.e., 19% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 360,413 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 87 others from the same source and published within six weeks on either side of this one. This one is in the 5th percentile – i.e., 5% of its contemporaries scored the same or lower than it.